Home > Insider Trading > Filing (0001209191-14-014628)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
353569	Quidel Corp	QDEL	In Vitro & In Vivo Diagnostic Substances (2835)	942573850

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1222788	John Tamerius	10165 Mckellar Court San Diego CA 92121	Svp - Clinical/Reg Affairs	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2014-02-25	24,464	$27.57	32,019	No	4	S	Direct
Common Stock	Acquisiton	2014-02-26	8,891	$12.63	40,910	No	4	M	Direct
Common Stock	Acquisiton	2014-02-26	13,891	$15.28	54,801	No	4	M	Direct
Common Stock	Disposition	2014-02-26	22,782	$27.82	32,019	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Options	Acquisiton	2014-02-24	21,068	$0.00	21,068	$27.57
Common Stock	Restricted Stock Units	Acquisiton	2014-02-24	961	$0.00	961	$0.00
Common Stock	Non-Qualified Stock Options	Disposition	2014-02-26	8,891	$0.00	8,891	$12.63
Common Stock	Non-Qualified Stock Options	Disposition	2014-02-26	13,891	$0.00	13,891	$15.28

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
21,068		2024-02-24	No	4	A	Direct
961			No	4	A	Direct
16,109	2013-03-02	2021-03-02	No	4	M	Direct
4,630	2014-01-18	2020-01-18	No	4	M	Direct

Footnotes

The weighted average sale price for these transactions was $27.566 per share, with a range of $27.69 to $27.50 per share. Upon request, the Reporting Person hereby understakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
The weighted average sale price for these transactions was $27.8187 per share, with a range of $27.72 to $27.97 per share. Upon request, the Reporting Person hereby understakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
10,534 shares will vest on the second anniversary date of the grant date, February 24, 2016. 5,267 shares will vest on the third anniversary date of the grant date, February 24, 2017. 5,267 shares will vest on the fourth anniversary date of the grant date, February 24, 2018.
Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock.
480 shares will vest on the second anniversary date of the grant date, February 24, 2016. 240 shares will vest on the third anniversary date of the grant date, February 24, 2017. 241 shares will vest on the fourth anniversary date of the grant date, February 24, 2018.